Westchester Capital Management Inc. Sells 669 Shares of Johnson & Johnson (NYSE:JNJ) Westchester Capital Management Inc. cut its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,500 shares of the company’s stock after selling 669 shares during the quarter. Johnson & Johnson accounts […]
https://www.americanbankingnew....s.com/2024/04/18/wes

Birch Hill Investment Advisors LLC Sells 1,480 Shares of Johnson & Johnson (NYSE:JNJ) Birch Hill Investment Advisors LLC trimmed its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 190,384 shares of the company’s stock after selling 1,480 shares during the quarter. Johnson & Johnson accounts for […]
https://www.americanbankingnew....s.com/2024/04/18/bir

Johnson & Johnson (NYSE:JNJ) Stock Position Decreased by First Personal Financial Services First Personal Financial Services lowered its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 4.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,345 shares of the company’s stock after selling 200 shares during the period. First Personal Financial Services’ holdings in Johnson […]
https://www.americanbankingnew....s.com/2024/04/18/joh

Johnson & Johnson (NYSE:JNJ) Shares Acquired by Clarius Group LLC Clarius Group LLC increased its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 11.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,025 shares of the company’s stock after purchasing an additional 2,870 shares during the period. Clarius […]
https://www.americanbankingnew....s.com/2024/04/18/joh

G2 Capital Management LLC OH Buys New Position in Johnson & Johnson (NYSE:JNJ) G2 Capital Management LLC OH purchased a new position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,570 shares of the company’s stock, valued at approximately $403,000. Other hedge funds have also […]
https://www.americanbankingnew....s.com/2024/04/18/g2-